IMDEA
proj_03

Dr. Isabel Rodriguez

Senior Research Professor

Isabel Rodriguez holds a Pharmacy degree from the University of Alcalá, Madrid and a Science PhD from the National University of Singapore. At IMDEA-Nanoscience she heads the Nanostructured Functional Surfaces Program where her research work is devoted to derive impactful applications from polymer micro and nano fabrication technologies. 

Recently, she has been working on the development and up-scaled processing via roll-to-roll nanoimprinting of multifunctional surfaces and particularly anti-reflective and self-cleaning surfaces with enhanced structural properties. Currently, she works on the development of antibacterial surfaces and cell culture platforms for regenerative medicine applications. On the EVO-Nano Project she leads the research to develop tumor on chip microfluidic systems by mimicking the major physiological barriers during nanoparticle tumor delivery for in vitro validation of the artificially evolved nanoparticle designs.

email: i.rodriguez@imdea.org  

Picture1

Dr. Jean Cacheux

Postdoctoral Researcher 

Jean Cacheux received his engineering degree in Physics from INSA (Toulouse, France) in 2014. Following he joined the MEMS group at LAAS-CNRS to carry out his Ph.D. research in collaboration with the Cancer Research Center of Toulouse till 2018. His research activities were focused on the detection of cancer biomarkers through nano and microfluidic technologies coupled to biofunctionalized sensors. His main undertaking with Evo-Nano is the fabrication and operation of microfluidic tumour on chip devices for in vitro nanoparticle validation. 

Picture2

Sergio Dávila Martínez

PhD Candidate 

Sergio Dávila obtained a bachelor´s degree in Health Biology at the University of Alcalá, Madrid in 2016. After that, he obtained a master´s degree in “Therapeutic targets and cell signaling: Research and development” from the Alcalá University (2017). At the moment, he is pursuing a PhD degree within the on the EVO-Nano project where he will be developing the tumour cell micro-environments on chip.